Jennifer Broad is a Community Support Worker with the Toronto Community Hep C Program where she co-facilitates treatment support groups and co-coordinates a research project evaluating peer-delivered point-of-care antibody outreach HCV testing. Jennifer has published and presented on the involvement of people with lived experience in HCV care both nationally and internationally.

Dr Phillip Read is the Director of the Kirketon Road Centre, a primary health care facility in Sydney, Australia, involved in the prevention, treatment and care of viral hepatitis among people who inject drugs.

Stelliana is a PhD student at the Burnet Institute and Monash University. Her work focuses on the impact of DAA hepatitis C treatment on health, wellbeing and everyday life.

Rod Knight is an Assistant Professor at UBC's Department of Medicine and a Research Scientist at the BC Centre on Substance Use.

Dr. Koo is an internal medicine resident physician at University of British Columbia (UBC). He completed a masters program in clinical epidemiology and research methodology at UBC and is currently engaging in various infectious diseases research.

Tianna received her B.A from the University of British Columbia. She currently works as a research assistant at Vancouver Infectious Diseases Centre where she researches HCV/HIV in vulnerable populations.

Sadeem is a researcher with indigenouswellness.Ca. She works under the mentorship of Dr. Alexandra King and Dr. Malcolm King. She is pursuing a Masters in Public Health (MPH) at Simon Fraser University. Her research interests include Indigenous wellness and health, with focus on hepatitis C and HIV in Canadian contexts.

A proud Mi'kmaq from Newfoundland. I have lived in most provinces of Canada and have always been drawn to First Nations and Inuit cultures. In the last five years, I have been working and volunteering with an AIDS organization and now expanded into Indigenous health research initiatives.

Nikitah Habraken is the Acting Hepatitis C Program Manager at the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). In collaboration with INHSU and the Kirby Institute at the University of New South Wales (UNSW) she leads an international education program designed to upskill health professionals, with the aim of expanding hepatitis C care beyond hospital settings

Dr. Eckhardt is an Assistant Professor at the NYU School of Medicine and Attending Physician at Bellevue Hospital in New York City. His research interest focuses on evaluating models of care to facilitate access, engagement, and retention of active injection drug users in HCV treatment and care.